Omnicell® Virtual Patent Marking

The following Omnicell products are protected by patents in the U.S. and elsewhere. This page is intended to serve as notice under 35 U.S.C. § 287(a) and the patent marking laws of various jurisdictions. Additional patents may be pending in the U.S. and elsewhere.

XT Series on Unity Enterprise Platform

U.S. Patents

6151536; 6272394; 6385505; 6435370; 6604019; 6975922; 7072855; 7571024; 7734369; 7835819; 8027749; 8073563; 8126590; 8131397; 8140186; 8155786; 8239062; 8280550; 8484049; 8773270; 9042607; 9158892; 9355220; 9365315; 9523534

Australian Patents

718057; 2004239714; 2010273562; 2011338579; 2012250824

Canadian Patents

2274088; 2523129; 2561239; 2684413

Chinese Patents

ZL 200880103580.X; ZL 201080035886.3; ZL 201180066961.7; 201280033147.X

Japanese Patents

4598773; 5577244; 5837490; 6022551

Korean Patents

10-1501035

Singapore Patents

157805

XT Series with AcuDose-Rx  Software

U.S. Patents

6151536; 6272394; 6385505; 6604019; 7072855; 7734369; 8773270; 9042607; 9365315; 9523534; 9471750

Australian Patents

718057; 2011338579; 2012250824

Canadian Patents

2274088; 2561239; 2684413

Chinese Patents

ZL 201180066961.7

Japanese Patents

6022551

XT Anesthesia Workstation

U.S. Patents

6011999; 6604019; 7072855; 7734369; 8773270; 9042607; 9355219; 9523534

Australian Patents

746286; 2011338579; 2012250824; 2012250821

Canadian Patents

2312751

Chinese Patents

ZL 201180066961.7

European Patents

1036365; 1598748

French Patents

1036365; 1598748

German Patents

69832298.3; 69840952.3

Great Britain Patents

1036365; 1598748

Japanese Patents

3845703; 6022551; 6034371

Spanish Patents

1036365; 1598748

XT Controlled Substance Manager

U.S. Patents

6151536; 6272394; 6385505; 6604019; 7072855; 7734369;8773270; 9042607; 9365315; 9523534

Australian Patents

2011338579; 2012250824

Chinese Patents

ZL 201180066961.7

Japanese Patents

6022551

Central Pharmacy Manager

U.S. Patents

7979310